Viewing Study NCT03918304


Ignite Creation Date: 2025-12-24 @ 9:06 PM
Ignite Modification Date: 2026-01-01 @ 1:44 PM
Study NCT ID: NCT03918304
Status: COMPLETED
Last Update Posted: 2025-10-23
First Post: 2019-04-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy - PLUS
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module References Module